cancer-patients / English

add

Cancer researchers said they started noticing a positive pattern among patients undergoing immunotherapy...

Conor McGregor, as the biggest star in MMA, often steals the headlines. During his active UFC days, it was those highlight-reel knockouts that grabbed attention. Now, he maintains that same traction as ‘The Notorious’ evolves into a…

Home for Healing supporters scared up some fun on Oct. 24 at the Venue at Westwind with the annual Monster Bash.

Maria Caulfield says: 'I'm very passionate about the NHS but it's not working for patients'.

A slow drug-release system has proven highly effective in treating certain bladder cancer patients whose tumors were previously unresponsive to therapy. A new targeted drug delivery system known as TAR-200 has shown remarkable results in a…

"All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for mRNA vaccines," Jarvis writes.

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. The regimen,…

(MedPage Today) -- Patients newly diagnosed with advanced breast cancer in 2025 would be expected to live 7 months longer on average than they did 15 years ago, according to an analysis of U.S. data.

Exercise can help women with advanced breast cancer better withstand both cancer treatments and the ravages of the disease, a clinical trial found.

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types of cancer. However,…

(MedPage Today) -- Prescriptions for GLP-1 receptor agonists for patients with cancer have increased despite a lack of clinical guidance on the drugs' safety and efficacy in cancer, a large retrospective review of health records showed.

Gilead Sciences Inc. (NASDAQ:GILD) announced on Friday data from the Phase 3 ASCENT-07 study of Trodelvy (sacituzumab govitecan-hziy) versus chemotherapy in HR+/HER2-negative metastatic breast cancer patients.

As the generics market for a particular drug gets crowded, competition on price might be driving quality issues that could harm patients.

SAN MARINO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- GenVivo, Inc., a clinical-stage biopharmaceutical company pioneering a patented, off-the-shelf vector platform to combat cancer by activating the patient's immune system against the…

Scientists have pinpointed a “Big Bang” moment in bowel cancer—when cells first evade the immune system. This early immune escape locks in how the cancer will behave as it grows. The discovery could help predict which patients respond to…

Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer according to new results presented at the Advanced Breast Cancer Eighth International Consensus Conference …

Ruben Torres, the father of a teen girl battling cancer, spoke exclusively with ABC7 Chicago, saying he endured "inhumane conditions" at the ICE facility in Broadview and his view of the American dream suddenly vanished while he was in DHS…

Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer, according to new results presented at the Advanced Breast Cancer Eighth International Consensus Conference …

Experts point to example of Denmark, where survival rates for some cancers are among the best in Europe